Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Ann Pathol ; 42(1): 79-84, 2022 Jan.
Article in French | MEDLINE | ID: mdl-33568264

ABSTRACT

This article presents the different pigmented lesions of the vulva (PLV) that are systematically found in 8 to 12% of women and are most often ignored. The histological aspect of physiological pigmentation and its modifications due to hormonal impregnation should be known by pathologists in order to better understand the very large variety of lesions.


Subject(s)
Melanoma , Melanosis , Nevus, Pigmented , Skin Neoplasms , Diagnosis, Differential , Female , Humans , Melanoma/diagnosis , Melanosis/diagnosis , Nevus, Pigmented/diagnosis , Skin Neoplasms/diagnosis , Vulva
2.
Indian J Pathol Microbiol ; 63(Supplement): S34-S40, 2020 Feb.
Article in English | MEDLINE | ID: mdl-32108624

ABSTRACT

BACKGROUND: Recently, we publish two case reports about association of nonspecific granulomatous prostatitis (NSGP) and eosinophilic metaplasia (EM) in benign prostatic epithelium. There is no investigation of large series of this association in medical literature. Aim of the current study is to investigate the frequency of association of NSGP and prostatic EM in a large series of cases and their relationship with the basic prostate pathology: benign prostatic hyperplasia (BPH), National Institutes of Health-category IV prostatitis (so-called histologic prostatitis (HP)), and prostatic adenocarcinoma (PCa). MATERIALS AND METHODS: A retrospective record review for NSGP was performed on a total of 2366 prostatic specimens of all types of material. All cases of NSGP were reviewed for the presence of EM, BPH, and HP. NSGP with EM-cases and control cases with high grade PCa with endocrine differentiation (so-called Paneth cell-like changes) were evaluated immunohistochemically. RESULTS: NSGP was found in nine cases (0.38%). EM was detected in benign perigranulomatous secretory epithelial cells in 100% of cases with NSGP and were closely associated with BPH and HP. Immunohistochemically, in 55.5% of cases with EM, there was weak focal apical false-positive staining for p504s. CONCLUSION: EM is a very common lesion in NSGP and reflects histologically a nonspecific cellular response, connected with repeated inflammation, in close relation with BPH and HP. We speculate that EM might serve as a morphological precursor of the immunologic phase of NSGP. This constant morphological finding could facilitate the histopathological differential diagnosis of NSGP with other types of granulomatous prostatitis and high grade PCa with or without endocrine differentiation.


Subject(s)
Eosinophilia , Epithelium/pathology , Granuloma/diagnosis , Granuloma/physiopathology , Prostatitis/diagnosis , Prostatitis/physiopathology , Aged, 80 and over , Case-Control Studies , Diagnosis, Differential , Histological Techniques , Humans , Male , Metaplasia/diagnosis , Metaplasia/pathology , Middle Aged , Paneth Cells , Prostate/cytology , Prostate/pathology , Prostatic Hyperplasia/diagnosis , Prostatic Hyperplasia/physiopathology , Prostatic Neoplasms/diagnosis , Prostatic Neoplasms/physiopathology , Retrospective Studies
3.
Acta Neuropathol Commun ; 7(1): 78, 2019 05 20.
Article in English | MEDLINE | ID: mdl-31109382

ABSTRACT

The recently described malignant neuro-epithelial tumors with histone H3F3A point mutations at G34 (NET-H3-G34) occur most often in cerebral hemispheres of teenagers and young adults, and have a generally adverse prognosis. These tumors have been histologically classified as glioblastoma or primitive neuroectodermal tumor (PNET) in the past, and have not been defined as a separate entity in the revised WHO classification of tumors of the CNS 2016. Here, we report two cases of NET-H3-G34 with glial and dysplastic ganglion cell components affecting teenagers. Patients were treated with surgery and radiochemotherapy with temozolomide. One patient underwent partial resection and deceased 21 months after diagnosis, while the other patient is alive without evidence of disease 15 months after total resection. So far, a dysplastic ganglion cell component has not been described in NET-H-G34, and its presence raises a possible relation to (anaplastic) gangliogliomas. Genome-wide copy number analysis did not provide unequivocal evidence that these tumors represent anaplastic variants of gangliogliomas, as opposed to NET-H3-G34. Our observations expand the morphologic spectrum of NET-H3-G34. Further cases of NET-H3-G34 with dysplastic ganglion cells should be clinically followed to find differences or similarities in their biological behavior, as compared to NET-H3-G34 and anaplastic gangliogliomas.


Subject(s)
Brain/pathology , Histones/genetics , Neoplasms, Neuroepithelial/genetics , Neoplasms, Neuroepithelial/pathology , Neuroglia/pathology , Adolescent , Humans , Male , Mutation
SELECTION OF CITATIONS
SEARCH DETAIL
...